Predictors for mechanical ventilation and short-term prognosis in patients with Guillain-Barré syndrome

Xiujuan Wu1, Chunrong Li2, Bing Zhang3

  • 1Neuroscience Center, Department of Neurology, the First Hospital of Jilin University, Jilin University, Xinmin Street 71#, 130021, Changchun, China. wuxiujuan861003@126.com.

Abstract

Insights

Guillain-Barré syndrome (GBS) patients requiring mechanical ventilation (MV) have distinct risk factors for MV and poor prognosis. Combined corticosteroid and immunoglobulin therapy predicted poor outcomes in severe GBS cases.

Area of Science:

  • Neurology
  • Immunology
  • Critical Care Medicine

Background:

  • Guillain-Barré syndrome (GBS) is an immune-mediated peripheral nervous system disorder.
  • Respiratory failure necessitating mechanical ventilation (MV) is a critical GBS complication.
  • Identifying modifiable risk factors for MV and poor prognosis in GBS is crucial for patient management.

Purpose of the Study:

  • To identify independent predictors for mechanical ventilation (MV) in GBS patients.
  • To determine factors associated with poor short-term prognosis in mechanically ventilated GBS patients.
  • To investigate the impact of treatment modalities on prognosis in severe GBS cases.

Main Methods:

  • Retrospective analysis of clinical data from 541 GBS patients (2003-2014).
  • Multivariate logistic regression used to identify independent predictors for MV and prognosis.
  • Analysis stratified by nadir Medical Research Council (MRC) sum score for prognostication.

Main Results:

  • Risk factors for MV included shorter onset-to-admission interval, facial nerve palsy, cranial nerve deficits, and lower MRC sum score; summer disease onset was protective.
  • Absence of antecedent infections and lower MRC sum score predicted poor short-term prognosis in MV patients.
  • Combined intravenous corticosteroids and immunoglobulin therapy predicted poor prognosis in MV patients with MRC sum scores of 0-12.

Conclusions:

  • Clinical predictors for MV and poor short-term prognosis in GBS patients are distinct.
  • Add-on intravenous corticosteroids pose a risk for poor prognosis in mechanically ventilated GBS patients with severe muscle weakness (MRC sum score 0-12).